Clinical Trial Update: Retrospective Survey of Safety of Fourth Dose Pentacel® in Children

View source ↗

Summary

A completed clinical trial update reporting safety results from a retrospective survey of a fourth dose of Pentacel in children.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Haemophilus Influenzae Type Infection
• Pertussis
• Poliomyelitis
• Tetanus

Drugs mentioned

• Pentacel (DTaP-Hib-IPV vaccine)

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Diphtheria, Pertussis | Status: COMPLETED | Results posted: 2010-04-02